Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Multiple Myeloma 5Lymphoma 3Plasmacytoma 2Paraproteinemias 2Leukemia, Plasma Cell 2Hemangioma 2Breast Neoplasms 2Recurrence 1Prostatic Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Lymphocytic, Chronic, B-Cell 1Head and Neck Neoplasms 1Glioma 1Gallstones 1Disease Progression 1Common Bile Duct Neoplasms 1Common Bile Duct Diseases 1Colorectal Neoplasms 1Carcinoma, Hepatocellular 1Brain Neoplasms 1

Interventions

Lenalidomide 4Bortezomib 4Dexamethasone 3vandetanib 2tumor necrosis factor-alpha, CNGRC fusion protein, human 2liposomal doxorubicin 2Doxorubicin 2tremelimumab 1tivozanib 1ricolinostat 1pomalidomide 1pazopanib 1nilotinib 1durvalumab 1avelumab 1abexinostat 1Transplantation, Autologous 1Tamoxifen 1Steroids 1Standard of Care 1Practice Guidelines as Topic 1Parenteral Nutrition 1Palliative Care 1Paclitaxel 1Nivolumab 1NVP-BKM120 1Melphalan 1Granulocyte Colony-Stimulating Factor 1Gemcitabine 1Filgrastim 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Disease Progression × Steroids × Clear all
NCT00272350 2019-12-05

ZD6474 to Treat Advanced Brain Cancer in Patients

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
83 enrolled
CNS

Brain Neoplasms, Glioma, Neoplasms, Disease Progression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡